The global micro-pumps market size is estimated to reach USD 6.79 billion by 2030, expanding at a CAGR of 17.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for Point-Of-Care-Testing (POCT) kits, rising awareness of controlled drug delivery systems, increasing miniaturization of medical devices, and increase in the research and development of pharmaceutical companies, are expected to drive the market.
In the product segment, the mechanical micro-pumps segment that dominated the market in 2021 is expected to serve as a key revenue-generating product owing to their extensive use in microfabrication technology and the rise in microfluidics research. Drug Delivery held a lucrative share in the application segment and is expected to grow substantially. The rising adoption of implanted drug delivery systems and medical devices, as well as the increasing research in the field of drug delivery, supported the growth of this segment. For instance, Sensile AG (A Subsidiary of Gerresheimer) Medical announced it had developed a wearable micro-pump for a European pharmaceutical company that is designed to treat Parkinson’s disease.
The onset of the pandemic positively affected the medical devices market by the end of 2020. The use of Micro-pumps in biomedical and pharmaceutical research for Covid-19 treatments increased. Individuals with chronic diseases required frequent monitoring of vital signs from time to time which led to the adoption of Point-Of-Care-Testing (POCT) kits. Even after the pandemic, there is a rise in the adoption of POCT kits at hospitals, clinics, and homes and hence, they are expected to support the growth of the market.
Request a free sample copy or view the report summary: Micro-pumps Market Report
The mechanical micro-pumps segment held 56.2% of the revenue share in 2023 owing to its extensive use in microfabrication technology, miniaturization of devices, and microfluidics
The drug delivery segment is projected to grow fast over the forecast period owing to the rise in the use of micro-pumps for the production of implanted drug delivery systems
The biotechnology and pharmaceutical companies segment held the largest revenue share in the global micro-pumps market in 2023 owing to the increasing demand for research and development.
North America micro-pumps market held a 49.8% revenue share in 2023 attributed to the region’s advanced healthcare infrastructure, high adoption rate of innovative technologies, and substantial investments in research and development.
Grand View Research has segmented the global micro-pumps market based on product, application, and end use:
Micro-pumps Product Outlook (Revenue, USD Million, 2018 - 2030)
Mechanical
Non-mechanical
Micro-pumps Application Outlook (Revenue, USD Million, 2018 - 2030)
Drug Delivery
In-vitro Diagnostics
Medical Devices
Others
Micro-pumps End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biotechnological & Pharmaceutical Companies
Hospitals & Diagnostic Centers
Academic & Research Institutes
Micro-pumps Regional Outlook (Revenue, USD Million, 2018 - 2028)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Micro-pumps Market
Bartels Mikrotechnik GmbH
Bürkert Fluid Control Systems
TOPS INDUSTRY & TECHNOLOGY CO., LTD.
The Lee Company
Xiamen AJK Technology Co., Ltd.
Xavitech
ALLDOO Micropump
Servoflo Corporation
Dolomite Microfluidics (Backtrace Holdings Ltd.)
TTp ventus
Arcmed Group (Halma)
"The quality of research they have done for us has been excellent..."